Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial-Reference-Cited by-同舟云学术

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

Published:2013-03 Issue:9869 Volume:381 Page:805-816
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Davies Christina,Pan Hongchao,Godwin Jon,Gray Richard,Arriagada Rodrigo,Raina Vinod,Abraham Mirta,Alencar Victor Hugo Medeiros,Badran Atef,Bonfill Xavier,Bradbury Joan,Clarke Michael,Collins Rory,Davis Susan R,Delmestri Antonella,Forbes John F,Haddad Peiman,Hou Ming-Feng,Inbar Moshe,Khaled Hussein,Kielanowska Joanna,Kwan Wing-Hong,Mathew Beela S,Mittra Indraneel,Müller Bettina,Nicolucci Antonio,Peralta Octavio,Pernas Fany,Petruzelka Lubos,Pienkowski Tadeusz,Radhika Ramachandran,Rajan Balakrishnan,Rubach Maryna T,Tort Sera,Urrútia Gerard,Valentini Miriam,Wang Yaochen,Peto Richard

Publisher

Elsevier BV

Subject

General Medicine

Reference22 articles.

1. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials;Lancet,2011

2. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005

3. Tamoxifen: the long and short of it;Swain;J Natl Cancer Inst,1996

4. Five years of tamoxifen—or more?;Peto;J Natl Cancer Inst,1996

5. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study;Fisher;J Natl Cancer Inst,2005

Cited by 1641 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment utilization and non-drug interventions for vasomotor symptoms in breast cancer survivors taking endocrine therapy: Real-world findings from the United States and Europe;Maturitas;2024-10

2. Postoperative radiotherapy in women with early operable breast cancer (Scottish Breast Conservation Trial): 30-year update of a randomised, controlled, phase 3 trial;The Lancet Oncology;2024-09

3. Venous thromboembolism in women with hormone-dependent breast cancer. To continue or discontinue hormonal treatment? Insights from the RIETE registry;Thrombosis Research;2024-09

4. Hormone receptor-positive early breast cancer in young women: A comprehensive review;Cancer Treatment Reviews;2024-09

5. Machine Learning-Based Predictive Model for Mortality in Female Breast Cancer Patients Considering Lifestyle Factors;Cancer Management and Research;2024-09